Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Apotex Inc.
483
•Apotex Inc.•April 28, 2025

Apotex Inc. – FDA 483, Apr 28, 2025

Record Details

An FDA inspection conducted from April 28 to May 9, 2025, at Apotex Inc. revealed significant concerns regarding quality control and investigation processes. The primary issues observed included a systemic failure to thoroughly review unexplained discrepancies and instances where products or components did not meet specifications, particularly concerning aseptic manufacturing. Specifically, the inspection highlighted numerous undocumented failures of leak tests on aseptic filling lines, including a recent event on April 30, 2025, where 34 leaking locations were identified on a critical filling line. Past leak test failures, dating back to 2023, were also cited for lacking comprehensive investigations into their root cause or impact on previously produced sterile drug products. Furthermore, the company"s approach to investigating anomalous individual bottle weight loss results during stability testing was found deficient. These investigations failed to assess if such results indicated compromised product integrity or to determine their impact on commercial batches. These observations underscore a lack of adherence to current Good Manufacturing Practices (cGMPs), indicating a need for Apotex Inc. to implement robust corrective actions. These actions must ensure all discrepancies are thoroughly documented and investigated, their root causes determined, and the potential impact on product quality and patient safety is comprehensively assessed for all affected batches.

Company
Apotex Inc.
Inspection date
April 28, 2025
Product type
Drugs
Office
Office of Inspections and Investigations
People
  • Wayne D. Mcgrath
  • Justin A. Boyd (Research Specialist II)
View Company Profile

ID · 449f09fe-98e2-4f37-8cfd-4c7dd87cbc93

Other documents for Apotex Inc.
  • 483 - 2022-09-14September 14, 2022
  • WARNING_LETTER - 2012-10-26October 26, 2012

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Apotex Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.